The following retrospective multicenter trial demonstrated a lower mortality 
rate for hemodynamically stable patients with sepsis and a lactate level 
between 2 and 4 mmol/L after implementing a sepsis resuscitation bundle. The 
decreased mortality was observed primarily in patient with heart failure or 
kidney disease. The bundle consisted of antibiotic administration within 3 
hours, repeat lactate testing within 1 to 4 hours, and orders for 30 mL/kg 
and/or 2 liters of intravenous fluid within 3 hours.



Liu, V. X., Morehouse, J. W., Marelich, G. P., Soule, J., Russell, T., Skeath, 
M., et al. (2015). Multicenter implementation of treatment bundle for sepsis 
patients with intermediate lactate values. American Journal of Respiratory 
Critical Care Medicine. [epub ahead of print]. First published online 22 Dec 
2015 as DOI: 10.1164/rccm.201507-1489OC




Rose Timmerman, DNP, RN,  CCRN-CSC-CMC, CCNS
Clinical Nurse Specialist
ICU, CTICU, CICU, & IMCU
Providence Alaska Medical Cener
[email protected]<mailto:[email protected]>
907-212-5673





From: Sepsisgroups [mailto:[email protected]] On 
Behalf Of Burger, Carolyn
Sent: Friday, May 20, 2016 10:05 AM
To: 'DHILLON, ROOPINDER'; [email protected]
Subject: Re: [Sepsis Groups] Sepsis-Fluid Resuscitation

Yes, struggling with this as well.  More for in patient setting than ER.

Carolyn Burger, RN, BS
Clinical Performance Coordinator
Performance Support
269-983-8896
[email protected]<mailto:[email protected]>

[healthy-heart[1]]



From: Sepsisgroups [mailto:[email protected]] On 
Behalf Of DHILLON, ROOPINDER
Sent: Tuesday, May 17, 2016 11:35 AM
To: 
[email protected]<mailto:[email protected]>
Subject: [Sepsis Groups] Sepsis-Fluid Resuscitation


Hi,

Is anyone facing physician pushbacks with Fluid Resuscitation of a 
sepsis/severe sepsis patient with CHF or Renal dysfunction? How are you 
educating physicians regarding this? Any strategies for persuading physicians 
to continue with fluid resuscitation in such patients.



Thank you,
Roopa Dhillon MBBS, MBA
Clinical Quality Analyst I
Quality Improvement/Clinical Outcomes
University Hospitals Elyria Medical Centre
630 East River
Elyria, Ohio  44035
T 440-329-4959 F 440-329-5971
Roopinder.Dhillon@UHhospitals<mailto:Roopinder.Dhillon@UHhospitals> .org
Quality Assurance/Peer Review Privileged Pursuant to Ohio Rev. Code secs. 
2305.24, 2305.25, 2305.251, 2305.252 and 2305.253
[UH jpg]


Visit us at 
www.UHhospitals.org<https://na01.safelinks.protection.outlook.com/?url=http%3a%2f%2fwww.UHhospitals.org&data=01%7c01%7cRosemary.Timmerman%40providence.org%7cc5abbec78b8c48bc701408d380d9aa2d%7c2e3190869a2646a3865f615bed576786%7c1&sdata=SkAaoV7wnhUJwMIZ9OMfdct4gBpV%2bq8agJZKnBjJ4kQ%3d>.

The enclosed information is STRICTLY CONFIDENTIAL and is intended for the
use of the addressee only. University Hospitals and its affiliates disclaim
any responsibility for unauthorized disclosure of this information to anyone
other than the addressee.

Federal and Ohio law protect patient medical information, including
psychiatric_disorders, (H.I.V) test results, A.I.Ds-related conditions,
alcohol, and/or drug_dependence or abuse disclosed in this email. Federal
regulation (42 CFR Part 2) and Ohio Revised Code section 5122.31 and
3701.243 prohibit disclosure of this information without the specific
written consent of the person to whom it pertains, or as otherwise permitted
by law.

________________________________
CONFIDENTIALITY NOTICE: This email and any attachments are for the
exclusive and confidential use of the intended recipient. If you are not
the intended recipient, please do not read, distribute or take action in
reliance upon this message. If you have received this in error, please
notify us immediately by return email and promptly delete this message
and its attachments from your computer system.

________________________________

This message is intended for the sole use of the addressee, and may contain 
information that is privileged, confidential and exempt from disclosure under 
applicable law. If you are not the addressee you are hereby notified that you 
may not use, copy, disclose, or distribute to anyone the message or any 
information contained in the message. If you have received this message in 
error, please immediately advise the sender by reply email and delete this 
message.
_______________________________________________
Sepsisgroups mailing list
[email protected]
http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org

Reply via email to